237 related articles for article (PubMed ID: 31803176)
1. An
Mishto M; Mansurkhodzhaev A; Ying G; Bitra A; Cordfunke RA; Henze S; Paul D; Sidney J; Urlaub H; Neefjes J; Sette A; Zajonc DM; Liepe J
Front Immunol; 2019; 10():2572. PubMed ID: 31803176
[TBL] [Abstract][Full Text] [Related]
2. In vitro proteasome processing of neo-splicetopes does not predict their presentation in vivo.
Willimsky G; Beier C; Immisch L; Papafotiou G; Scheuplein V; Goede A; Holzhütter HG; Blankenstein T; Kloetzel PM
Elife; 2021 Apr; 10():. PubMed ID: 33875134
[TBL] [Abstract][Full Text] [Related]
3. Response: Commentary: An
Mishto M; Rodriguez-Hernandez G; Neefjes J; Urlaub H; Liepe J
Front Immunol; 2021; 12():679836. PubMed ID: 34326838
[No Abstract] [Full Text] [Related]
4. Commentary: An
Beer I
Front Immunol; 2021; 12():523906. PubMed ID: 34326832
[No Abstract] [Full Text] [Related]
5. Proteasome-Generated
Mansurkhodzhaev A; Barbosa CRR; Mishto M; Liepe J
Front Immunol; 2021; 12():614276. PubMed ID: 33717099
[TBL] [Abstract][Full Text] [Related]
6. Population-level distribution and putative immunogenicity of cancer neoepitopes.
Wood MA; Paralkar M; Paralkar MP; Nguyen A; Struck AJ; Ellrott K; Margolin A; Nellore A; Thompson RF
BMC Cancer; 2018 Apr; 18(1):414. PubMed ID: 29653567
[TBL] [Abstract][Full Text] [Related]
7. A Recurrent Mutation in Anaplastic Lymphoma Kinase with Distinct Neoepitope Conformations.
Toor JS; Rao AA; McShan AC; Yarmarkovich M; Nerli S; Yamaguchi K; Madejska AA; Nguyen S; Tripathi S; Maris JM; Salama SR; Haussler D; Sgourakis NG
Front Immunol; 2018; 9():99. PubMed ID: 29441070
[TBL] [Abstract][Full Text] [Related]
8. Identification and affinity enhancement of T-cell receptor targeting a KRAS
Zhang M; Xu W; Luo L; Guan F; Wang X; Zhu P; Zhang J; Zhou X; Wang F; Ye S
Commun Biol; 2024 Apr; 7(1):512. PubMed ID: 38684865
[TBL] [Abstract][Full Text] [Related]
9. Proteasomes generate spliced epitopes by two different mechanisms and as efficiently as non-spliced epitopes.
Ebstein F; Textoris-Taube K; Keller C; Golnik R; Vigneron N; Van den Eynde BJ; Schuler-Thurner B; Schadendorf D; Lorenz FK; Uckert W; Urban S; Lehmann A; Albrecht-Koepke N; Janek K; Henklein P; Niewienda A; Kloetzel PM; Mishto M
Sci Rep; 2016 Apr; 6():24032. PubMed ID: 27049119
[TBL] [Abstract][Full Text] [Related]
10. Identification of neoepitope reactive T-cell receptors guided by HLA-A*03:01 and HLA-A*11:01 immunopeptidomics.
Ade CM; Sporn MJ; Das S; Yu Z; Hanada KI; Qi YA; Maity T; Zhang X; Guha U; Andresson T; Yang JC
J Immunother Cancer; 2023 Sep; 11(9):. PubMed ID: 37758652
[TBL] [Abstract][Full Text] [Related]
11. High-affinity oligoclonal TCRs define effective adoptive T cell therapy targeting mutant KRAS-G12D.
Sim MJW; Lu J; Spencer M; Hopkins F; Tran E; Rosenberg SA; Long EO; Sun PD
Proc Natl Acad Sci U S A; 2020 Jun; 117(23):12826-12835. PubMed ID: 32461371
[TBL] [Abstract][Full Text] [Related]
12. Overlapping epitopes encompassing a point mutation (12 Gly-->Arg) in p21 ras can be recognized by HLA-DR, -DP and -DQ restricted T cells.
Fossum B; Gedde-Dahl T; Hansen T; Eriksen JA; Thorsby E; Gaudernack G
Eur J Immunol; 1993 Oct; 23(10):2687-91. PubMed ID: 7691613
[TBL] [Abstract][Full Text] [Related]
13. Human leukocyte antigens A*3001 and A*3002 show distinct peptide-binding patterns of the Mycobacterium tuberculosis protein TB10.4: consequences for immune recognition.
Axelsson-Robertson R; Ahmed RK; Weichold FF; Ehlers MM; Kock MM; Sizemore D; Sadoff J; Maeurer M
Clin Vaccine Immunol; 2011 Jan; 18(1):125-34. PubMed ID: 21084459
[TBL] [Abstract][Full Text] [Related]
14. Facts and Hopes in Immunotherapy Strategies Targeting Antigens Derived from KRAS Mutations.
Linette GP; Bear AS; Carreno BM
Clin Cancer Res; 2024 May; 30(10):2017-2024. PubMed ID: 38266167
[TBL] [Abstract][Full Text] [Related]
15. [Preclinical study of T cell receptor specifically reactive with
Cheng XJ; Jiang D; Zhang LH; Wang JH; Li YZ; Zhai JH; Yan BQ; Zhang LL; Xie XW; Li ZY; Ji JF
Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Oct; 54(5):884-895. PubMed ID: 36241231
[TBL] [Abstract][Full Text] [Related]
16. Efficient identification of novel HLA-A(*)0201-presented cytotoxic T lymphocyte epitopes in the widely expressed tumor antigen PRAME by proteasome-mediated digestion analysis.
Kessler JH; Beekman NJ; Bres-Vloemans SA; Verdijk P; van Veelen PA; Kloosterman-Joosten AM; Vissers DC; ten Bosch GJ; Kester MG; Sijts A; Wouter Drijfhout J; Ossendorp F; Offringa R; Melief CJ
J Exp Med; 2001 Jan; 193(1):73-88. PubMed ID: 11136822
[TBL] [Abstract][Full Text] [Related]
17. Identification of a Promiscuous Epitope Peptide Derived From HSP70.
Matsui H; Hazama S; Tamada K; Udaka K; Irie A; Nishimura Y; Miyakawa T; Doi S; Nakajima M; Kanekiyo S; Tokumitsu Y; Shindo Y; Tomochika S; Yoshida S; Iida M; Suzuki N; Takeda S; Yamamoto S; Yoshino S; Ueno T; Nagano H
J Immunother; 2019 Sep; 42(7):244-250. PubMed ID: 31398179
[TBL] [Abstract][Full Text] [Related]
18. T cell epitopes encompassing the mutational hot spot position 61 of p21 ras. Promiscuity in ras peptide binding to HLA.
Gedde-Dahl T; Spurkland A; Fossum B; Wittinghofer A; Thorsby E; Gaudernack G
Eur J Immunol; 1994 Feb; 24(2):410-4. PubMed ID: 7507844
[TBL] [Abstract][Full Text] [Related]
19. Potential Mimicry of Viral and Pancreatic β Cell Antigens Through Non-Spliced and
Mishto M; Mansurkhodzhaev A; Rodriguez-Calvo T; Liepe J
Front Immunol; 2021; 12():656451. PubMed ID: 33936085
[TBL] [Abstract][Full Text] [Related]
20. Human CD8(+) T Cells Target Multiple Epitopes in Respiratory Syncytial Virus Polymerase.
Burbulla D; Günther PS; Peper JK; Jahn G; Dennehy KM
Viral Immunol; 2016 Jun; 29(5):307-14. PubMed ID: 27070377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]